VivoSim Labs, Inc. VIVS
0.12 USD 0.00 (-2.83%)
As ofNov 17, 2026, 2:59 PM EST
0.118 Day range 0.1259
0.118 52-week range 3.40
- YTD
- -93.36%
- 1 year
- -94.73%
- Market cap
- 2.44M
- EPS (ttm)
- -4.47
- YTD return
- -93.36%
- 1-year return
- -94.73%
- Volume
- 217.13K
- Avg volume
- 981.73K
- Open
- 0.1229
- Previous close
- 0.1237
- Day's range
- 0.118 – 0.1259
- 52-week range
- 0.118 – 3.40
5D -0.0149 (-10.64%)
Fundamental scorecard
5 of 25 checks passed on VIVS’s reported financials
5of 25 checks passed
- Value 2 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
VIVS Revenue — quarterly 51.00K
VIVS Net income — quarterly -475.00K
VIVS EPS — quarterly -0.03
News
VivoSim Labs Q2 EPS $(0.03) Up From $(0.98) YoY, Sales $51.000K Up From $28.000K YoY
VivoSim Labs to Showcase Multiparametric Human 3D Tissue Safety Data at the American College of Toxicology (ACT) 47th Annual Meeting VivoSim Labs Partners With Chemveda Life Sciences To Test, Screen AI-Derived Drug Compounds In VivoSim's NAMkind 3D Tissue Models
VivoSim Labs To Extend Its Human Tissue Platform Beyond Toxicology With Efficacy Testing Services Built On NAMkind Disease Models Of The Liver And Intestine
Your note
Sign in to keep a note on VIVS — it syncs with the Stock Master app.
